# US 2016/0355801 A1 · Nitrilases, nucleic acids encoding them and methods for making and using them

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355801 A1
- Document ID: US20160355801A1
- Status: Published application
- Kind: A1
- Application number: 15/064,269
- Filed: 2016-03-08
- Published: 2016-12-08
- Earliest claimed: 1999-12-29
- Assignees: BASF Enzymes LLC
- Applicants: BASF Enzymes LLC
- Inventors: KELVIN WONG; JAY M. SHORT; MARK J. BURK; GRACE DESANTIS; ROBERT FARWELL; KELLY CHATMAN
- Web page: https://patentgrep.com/patent/US20160355801A1

## CPC

- C12N 9/78: acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N 15/00: Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00)
- C12P 7/42: Hydroxy-carboxylic acids
- C12P 13/002: {Nitriles (-CN)}
- C12P 13/04: Alpha- or beta- amino acids {(other amino acids C12P13/005)}
- C12P 41/006: {by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures}
- C12Y 305/05001: Nitrilase (3.5.5.1)
- Y02P 20/52: using catalysts, e.g. selective catalysts
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The invention relates to nitrilases and to nucleic acids encoding the nitrilases. In addition methods of designing new nitrilases and method of use thereof are also provided. The nitrilases have increased activity and stability at increased pH and temperature.

## Claims

### Claim at position 1

1-13. (canceled)

### Claim 14

An isolated, synthetic or recombinant nucleic acid, encoding a polypeptide having nitrilase activity, comprising:
(a) a nucleic acid having a sequence at least 85% identical to SEQ ID NO: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153, 155, 157, 159, 161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181, 183, 185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209, 211, 213, 215, 217, 219, 221, 223, 225, 227, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, 255, 257, 259, 261, 263, 265, 267, 269, 271, 273, 275, 277, 279, 281, 283, 285, 287, 289, 291, 293, 295, 297, 299, 301, 303, 305, 307, 309, 311, 313, 315, 317, 319, 321, 323, 325, 327, 329, 331, 333, 335, 337, 339, 341, 343, 345, 347, 349, 351, 353, 355, 357, 359, 361, 363, 365, 367, 369, 371, 373, 375, 377, 379, 381, 383 or 385; or
(b) nucleic acid encoding a polypeptide comprising consecutive amino acids having a sequence at least 85% identical to SEQ ID NO:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 226, 228, 230, 232, 234, 236, 238, 240, 242, 244, 246, 248, 250, 252, 254, 256, 258, 260, 262, 264, 266, 268, 270, 272, 274, 276, 278, 280, 282, 284, 286, 288, 290, 292, 294, 296, 298, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 320, 322, 324, 326, 328, 330, 332, 334, 336, 338, 340, 342, 344, 346, 348, 350, 352, 354, 356, 358, 360, 362, 364, 366, 368, 370, 372, 374, 376, 378, 380, 382, 384 or 386; or
(c) a nucleic acid completely complementary to (a) or (b).

### Claim 15 (depends on 14)

A nucleic acid vector capable of replication in a host cell, wherein the vector comprises the nucleic acid of claim 14.

### Claim 16 (depends on 14)

A host cell comprising the nucleic acid of claim 14.

### Claim 17 (depends on 16)

A host organism comprising the host cell of claim 16.

### Claim 18 (depends on 14)

The isolated, synthetic or recombinant nucleic acid of claim 14, wherein the nucleic acid is affixed to a solid support, wherein optionally the solid support is selected from the group of a gel, a resin, a polymer, a ceramic, a glass, a microelectrode and any combination thereof.

### Claim 19 (depends on 14)

A method for making a polypeptide having nitrilase activity, the method comprising (a) introducing the nucleic acid of claim 14 encoding the polypeptide into a host cell under conditions that permit production of the polypeptide by the host cell, and (b) recovering the recombinant polypeptide so produced.

### Claim 20 (depends on 14)

A kit comprising the nucleic acid of claim 14, or a fragment thereof encoding a polypeptide having nitrilase activity, and a buffer.

### Claim 21 (depends on 14)

The isolated, synthetic or recombinant nucleic acid of claim 14, further consisting of one or more mutations, wherein: nucleotides 163-165 are substituted with AAA, AAG, GGT, GGC, GGA, GGG, CAA, or CAG; nucleotides 178-180 are substituted with GAA or GAG; nucleotides 331-333 are substituted with TCT, TCC, TCA, TCG, AGT, or AGC; nucleotides 568-570 are substituted with CAT, CAC, TCT, TCC, TCA, TCG, AGT, AGC, ACT, ACC, ACA, TCA, TAT, TAC, ATG or ACG; nucleotides 571-573 are substituted with TTA, TTG, CTT, CTC, CTA, CTG, GTT, GTC, GTA, GTG, ATG, ACT, ACC, ACA, GAT, GAC, GGT, GGC, GGA, GGG, GAA, GAG, TAT, TAC, or ACG; nucleotides 595-597 are substituted with GAA, GAG, TTA, TTG, CTT, CTC, CTA, or CTG; nucleotides 664-666 of SEQ ID NO: 209 are substituted with TTA, TTG, CTT, CTC, CTA, or CTG; or any combination thereof.

### Claim 22

An isolated, synthetic or recombinant polypeptide comprising consecutive amino acids having a sequence at least 85% identical to SEQ ID NO:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 226, 228, 230, 232, 234, 236, 238, 240, 242, 244, 246, 248, 250, 252, 254, 256, 258, 260, 262, 264, 266, 268, 270, 272, 274, 276, 278, 280, 282, 284, 286, 288, 290, 292, 294, 296, 298, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 320, 322, 324, 326, 328, 330, 332, 334, 336, 338, 340, 342, 344, 346, 348, 350, 352, 354, 356, 358, 360, 362, 364, 366, 368, 370, 372, 374, 376, 378, 380, 382, 384 or 386, wherein the polypeptide has nitrilase activity.

### Claim 23 (depends on 22)

A codon-optimized polypeptide of claim 22, or a fragment thereof, having nitrilase activity, wherein the codon usage is optimized for a particular organism or cell.

### Claim 24 (depends on 22)

The polypeptide of claim 22, or a fragment thereof, having nitrilase activity, or a peptidomimetic thereof having nitrilase activity, wherein the polypeptide, fragment, or peptidomimetic is affixed to a solid support, wherein the solid support is selected from the group consisting of a gel, a resin, a polymer, a ceramic, a glass, a microelectrode and any combination thereof.

### Claim 25 (depends on 22)

The polypeptide of claim 22, wherein the nitrilase activity comprises hydrolyzing a nitrile to a carboxylic acid.

### Claim 26 (depends on 22)

The polypeptide of claim 22, wherein the nitrilase activity comprises hydrolyzing a cyanohydrin moiety or an aminonitrile moiety of a molecule.

### Claim 27

A method for making a chiral alpha-hydroxy acid molecule or a chiral amino acid molecule, the method comprising admixing a molecule having a cyanohydrin moiety or an aminonitrile moiety with at least one polypeptide having an amino acid sequence at least 85% identical to any one of SEQ ID NOS: 1-386 or a fragment thereof, or a peptidomimetic thereof, having enantio-selective nitrilase activity.

### Claim 28 (depends on 22)

A method for making a composition or an intermediate thereof, the method comprising admixing a precursor of the composition or intermediate, wherein the precursor comprises a cyanohydrin moiety or an aminonitrile moiety, with at least one polypeptide of claim 22, or a fragment or peptidomimetic thereof having nitrilase activity, hydrolyzing the cyanohydrin or the aminonitrile moiety in the precursor thereby making the composition or the intermediate thereof.

### Claim 29

An isolated, synthetic, or recombinant variant polypeptide having a nitrilase activity wherein the variant polypeptide is an amino acid sequence of SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 226, 228, 230, 232, 234, 236, 238, 240, 242, 244, 246, 248, 250, 252, 254, 256, 258, 260, 262, 264, 266, 268, 270, 272, 274, 276, 278, 280, 282, 284, 286, 288, 290, 292, 294, 296, 298, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 320, 322, 324, 326, 328, 330, 332, 334, 336, 338, 340, 342, 344, 346, 348, 350, 352, 354, 356, 358, 360, 362, 364, 366, 368, 370, 372, 374, 376, 378, 380, 382, 384 or 386; and a mutation at an amino acid position selected from: 55, 60, 111, 190, 191, 199, or any combination thereof.

### Claim 30 (depends on 29)

The polypeptide of claim 29, wherein the mutation is selected from: A55G, A55K, I60E, N111S, A190T, A190S, A190H, F191L, F191T, F191M, F191V, M199E, M199L, or any combination thereof.

### Claim 31 (depends on 29)

The polypeptide of claim 29, wherein the nitrilase activity comprises hydrolyzing a nitrile to a carboxylic acid.

### Claim 32 (depends on 29)

The polypeptide of claim 29, wherein the nitrilase activity comprises hydrolyzing a cyanohydrin moiety or an aminonitrile moiety of a molecule.

### Claim 33 (depends on 29)

The polypeptide of claim 29, wherein the nitrilase activity comprises an enantio-selective nitrilase activity and the enantio-selective activity comprises generating a chiral alpha-hydroxy acid molecule or a chiral amino acid molecule by catalyzing the hydrolysis of a molecule having a cyanohydrin moiety or an aminonitrile moiety.

### Claim 34 (depends on 29)

The polypeptide of claim 29, wherein the nitrilase activity comprises hydrolysis of a hydroxyglutaryl nitrile to generate an ethyl 4-cyano-3-hydroxybutyric acid.

### Claim 35 (depends on 29)

The polypeptide of claim 29, wherein the polypeptide is made by a method comprising introducing a nucleic acid encoding the polypeptide into a host cell, wherein the host cell produces the polypeptide, and optionally the method further comprises recovering the polypeptide.

### Claim 36

An isolated, synthetic, or recombinant variant polypeptide having a nitrilase activity wherein the variant polypeptide is an amino acid sequence of SEQ ID NO:196, 206, 208, 210, or 238; and a mutation at an amino acid position selected from: 55, 60, 111, 190, 191, 199, or any combination thereof; and wherein the variant polypeptide is an amino acid sequence having at least 90% sequence identity with the parent amino acid sequence.
